R

Ralph A. Neumüller

Boehringer Ingelheim (Austria)

ORCID: 0000-0002-1514-6278

Publishes on Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Advanced biosensing and bioanalysis techniques. 64 papers and 3.7k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

64Publications

3.7kTotal Citations

First publication: 2006First senior author: 2016

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Advanced biosensing and bioanalysis techniques RNA Interference and Gene Delivery CRISPR and Genetic Engineering

Top publicationsby citations

Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer

Ralph A. Neumüller, Juergen A. Knoblich|Genes & Development|2009

Cited by 404

Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers

Birgit Wilding, Ralph A. Neumüller|Cancer Discovery|2024

Cited by 43